Free Trial

Caisse Des Depots ET Consignations Buys Shares of 11,250 DaVita Inc. (NYSE:DVA)

DaVita logo with Medical background
Remove Ads

Caisse Des Depots ET Consignations bought a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 11,250 shares of the company's stock, valued at approximately $1,682,000.

Several other institutional investors have also recently bought and sold shares of the company. SBI Securities Co. Ltd. bought a new position in shares of DaVita in the 4th quarter valued at about $41,000. Quarry LP acquired a new position in DaVita during the third quarter worth approximately $60,000. Venturi Wealth Management LLC raised its stake in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after buying an additional 152 shares during the period. Versant Capital Management Inc boosted its stake in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after acquiring an additional 169 shares during the period. Finally, Blue Trust Inc. increased its holdings in shares of DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after acquiring an additional 131 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

DaVita Stock Performance

DaVita stock traded down $0.24 during midday trading on Tuesday, hitting $152.73. The company's stock had a trading volume of 185,124 shares, compared to its average volume of 882,518. The company has a 50-day moving average price of $157.13 and a two-hundred day moving average price of $157.52. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The company has a market cap of $12.22 billion, a price-to-earnings ratio of 14.22, a PEG ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.

Analyst Upgrades and Downgrades

DVA has been the subject of several research reports. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. StockNews.com downgraded shares of DaVita from a "buy" rating to a "hold" rating in a report on Friday, March 21st. Barclays increased their price target on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday, February 18th. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $166.33.

Read Our Latest Research Report on DaVita

About DaVita

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads